|
Post by beardawg on May 27, 2016 16:25:40 GMT -5
Did anyone suggest during the stockholders meeting that they do a live demonstration showing real time control of blood glucose levels during the ADA conference? Maybe do it at the end of the first presentation and people can periodically come back by the booth to check and they can give updates during the other presentations. Anybody have the ear of management and can pass along? I remember someone suggesting this before, but Sanofi was handling the booth then. What if it failed? That could be a serious problem given it's the ADA meeting. Why would it fail? It works, plain and simple. It's insulin, which does what insulin does.
|
|
|
Post by capnbob on May 27, 2016 22:04:42 GMT -5
What if it failed? That could be a serious problem given it's the ADA meeting. Why would it fail? It works, plain and simple. It's insulin, which does what insulin does. "Why would it fail? It works, plain and simple." Napoleon probably thought something similar at Waterloo.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 27, 2016 22:58:38 GMT -5
I completely agree with you here, capnbob—They would never do that. I could maybe see a video on their website in the future of something along those lines, but this is a professional convention, not a flea market. It's a great idea that I personally think could be implemented, but not in this setting.
|
|
|
Post by beardawg on May 27, 2016 23:36:44 GMT -5
Why would it fail? It works, plain and simple. It's insulin, which does what insulin does. "Why would it fail? It works, plain and simple." Napoleon probably thought something similar at Waterloo. Completely different relationships. One is science and biology, the other is happenstance.
|
|
|
Post by BlueCat on May 29, 2016 0:19:33 GMT -5
I completely agree with you here, capnbob—They would never do that. I could maybe see a video on their website in the future of something along those lines, but this is a professional convention, not a flea market. It's a great idea that I personally think could be implemented, but not in this setting. Its the floor at a convention. And yea, neon signs and all. The name of the game is getting traffic to the booth so you can start a conversation, provide materials, exchange cards, and swipe their badges so you can call them later. I think the challenge for Afrezza is that the charts are compelling. But even more so seeing it in real life. That makes an impression that the FUDsters can't simply remove.
|
|
|
Post by prvs on May 29, 2016 6:26:52 GMT -5
I completely agree with you here, capnbob—They would never do that. I could maybe see a video on their website in the future of something along those lines, but this is a professional convention, not a flea market. It's a great idea that I personally think could be implemented, but not in this setting. I agree. Imagine a person standing by the booth holding a CGM and saying Look, Look! I'm right in range. Want to see me eat something and see what happens? Sounds like something you would see at a country AG fair.
|
|
|
Post by peppy on May 29, 2016 16:44:56 GMT -5
any one know if these so called 6 game changing abstracts are just posters? or will be presented in a product theater? if being presented , who is ? 931-P / 931 - Technosphere® Inhaled Human Insulin Has a More Rapid Onset of Action Than Subcutaneous Insulins: Meta-analysis of Clamp Data from Three Clinical Studies Itinerary June 12, 2016, 12:00 - 1:00 PM Poster Hall (Halls D-E) Authors YOUSSEF HIJAZI, ANDERS BOSS, THOMAS KLABUNDE, RAPHAEL DAHMEN, DIETHER RUEPPEL, ROBERT A. BAUGHMAN, Frankfurt, Germany, Bridgewater, NJ, Danbury, CT Disclosures Y. Hijazi: Employee; Author; Sanofi. A. Boss: Employee; Author; Sanofi. T. Klabunde: Employee; Author; Sanofi. R. Dahmen: Employee; Author; Sanofi. D. Rueppel: Employee; Author; Sanofi. R.A. Baughman: Employee; Author; MannKind Corporation. Abstract embargoed at this time.? meaning until they are released? Nothing has been said about Afrezza pricing since.... the conference after the break up timeframe. Paraphrasing the comments I remember, "consults" on Afrezza pricing going forward.
|
|
|
Post by agedhippie on May 29, 2016 17:56:47 GMT -5
Nothing has been said about Afrezza pricing since.... the conference after the break up timeframe. Paraphrasing the comments I remember, "consults" on Afrezza pricing going forward.
At this point the JV in the form of Sanofi effectively still set the price as they are the only ones selling so unless Mannkind drops the price to Sanofi I cannot see the price moving. Sanofi is still taking a loss on each unit of Afrezza they sell and are not going to be keen on taking a bigger loss!
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 29, 2016 18:34:08 GMT -5
Nothing has been said about Afrezza pricing since.... the conference after the break up timeframe. Paraphrasing the comments I remember, "consults" on Afrezza pricing going forward.
At this point the JV in the form of Sanofi effectively still set the price as they are the only ones selling so unless Mannkind drops the price to Sanofi I cannot see the price moving. Sanofi is still taking a loss on each unit of Afrezza they sell and are not going to be keen on taking a bigger loss! I wouldn't think any loss now as it's just the product cost and distribution cut. No other costs Vice President's , US lead , director 's shouldn't be charging to the JAC. But not so sure what else being charged as mnkd had 5 mil l?? oss from JAC in the first Q
|
|
|
Post by capnbob on May 29, 2016 19:55:17 GMT -5
Nothing has been said about Afrezza pricing since.... the conference after the break up timeframe. Paraphrasing the comments I remember, "consults" on Afrezza pricing going forward.
At this point the JV in the form of Sanofi effectively still set the price as they are the only ones selling so unless Mannkind drops the price to Sanofi I cannot see the price moving. Sanofi is still taking a loss on each unit of Afrezza they sell and are not going to be keen on taking a bigger loss! Has MNKD inquired of SNY about lowering the price? What is the shelf life? Reading through some tweets left an impression that at least some SNY material is expiring in September, I would think perhaps SNY might be willing to lower the price to help move inventory out before it expires.
|
|
|
Post by BlueCat on May 29, 2016 22:13:27 GMT -5
I completely agree with you here, capnbob—They would never do that. I could maybe see a video on their website in the future of something along those lines, but this is a professional convention, not a flea market. It's a great idea that I personally think could be implemented, but not in this setting. I agree. Imagine a person standing by the booth holding a CGM and saying Look, Look! I'm right in range. Want to see me eat something and see what happens? Sounds like something you would see at a country AG fair. Tradeshows are country AG fairs. Granted, Mike's team would have to ask a few of their target audience to understand if this would make an impression. But anyone who has done the circuit can tell you - attention is the name of the game. Toys, hats, espresso machines. Years ago, larger co's during times of large budgets would contact Cirque du Soleil to perform in their booths. 3-eared pig, anyone?
|
|
|
Post by LosingMyBullishness on May 30, 2016 6:13:41 GMT -5
3-eared pig? What happened to the 'funny looking cucumber? Always good for a laugh in the ol' days.
|
|
|
Post by mnkdfann on May 30, 2016 7:31:12 GMT -5
I agree. Imagine a person standing by the booth holding a CGM and saying Look, Look! I'm right in range. Want to see me eat something and see what happens? Sounds like something you would see at a country AG fair. Tradeshows are country AG fairs. Tradeshows are, sure. But is the ADA conference a tradeshow or is it a serious scientific meeting? I've never been to the ADA conference, but the web site suggests it is the latter (a scientific meeting): www.afassanoco.com/ada/I've been to many scientific conferences in my day, and never seen the sort of gimmicks some have suggested. (IOTW, exhibitors at a scientific meeting behave differently than exhibitors at a tradeshow or county fair.)
|
|
|
Post by tayl5 on May 30, 2016 7:56:41 GMT -5
Tradeshows are country AG fairs. Tradeshows are, sure. But is the ADA conference a tradeshow or is it a serious scientific meeting? I've never been to the ADA conference, but the web site suggests it is the latter (a scientific meeting): www.afassanoco.com/ada/I've been to many scientific conferences in my day, and never seen the sort of gimmicks some have suggested. (IOTW, exhibitors at a scientific meeting behave differently than exhibitors at a tradeshow or county fair.) The platform presentations and poster are strictly science and medicine. Market leaders like the biopharmas and diagnostics companies generally take a conservative approach in their exhibits. Their exhibits also are highly visible, have a large footprint and tend to be on everyone's list anyway. The farther you go from this bright center of the universe, the more likely you are to see companies trying hard to attract attention and create some buzz. I don't think a demo featuring Afrezza would be out of place. It might be a challenge to get through it while not making claims that go beyond the label.
|
|
|
Post by matt on May 30, 2016 8:15:42 GMT -5
Tradeshows are country AG fairs. Tradeshows are, sure. But is the ADA conference a tradeshow or is it a serious scientific meeting? I've never been to the ADA conference, but the web site suggests it is the latter (a scientific meeting): www.afassanoco.com/ada/I've been to many scientific conferences in my day, and never seen the sort of gimmicks some have suggested. (IOTW, exhibitors at a scientific meeting behave differently than exhibitors at a tradeshow or county fair.) Big meetings like the ADA are mostly serious science, partly trade show, with a dash of street theater thrown in. The plenary session and scheduled presentations are all serious science as you would expect, as are the poster sessions. These are all vetted by the conference organizers and it is very bad for your karma as a scientist to cheapen the event. There can also be PAID presentations which take place before or after the main conference (i.e. 6:30-8:00 in the morning or early evening). These are quasi-promotional scientific lectures sponsored by pharma companies and, depending on the meeting, can be seriously informative or so full of fluff that you regret waking up that early.
The exhibition floor is pure capitalism at its finest. Companies rent booths to display their products and services, and nobody expects this to be objective science. It is where convention delegates can collect a lot of freebie promotional items and brochures that they will probably never read later. Mostly it is a good chance for smaller organizations to get their name out there. Part of the game is to get attention on YOUR booth, which requires a bit of showmanship if you do not have the dollars for a huge space guaranteed to attract attention, hence the need for a bit of street theater.
The most effective street theater I can recall was from an International AIDS conference I attended in the late 1990's where Durex had a booth with free condoms and a display where they would blow up a condom with an air compressor until it burst with a big boom. People stopped and watched multiple times (condoms can hold a very impressive amount of air before bursting). It was a good display because it was relevant to their product and got them lots of foot traffic; I think that was fair game given the conference. Depending on patient activism, some meetings can be part science and part political events; the international AIDS conferences were always something of a circus (think San Francisco gay pride parade meets the Nobel presentation awards) but way more fun that the other medical meetings I have attended.
I agree that for the ADA meeting a "live demonstration" would probably not be appropriate. Most attendees already discount the truth of anything shown in the commercial exhibition hall and I don't think that demonstration would be enough to stop traffic.
|
|